Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Clarus closes $660m bio fund

This article was originally published in Clinica

Executive Summary

Clarus Ventures has raised $660m for its second life sciences investment fund, Clarus II. The money will be invested over three years in medical technology, biotechnology and specialty pharmaceutical companies. Clarus said between $20-60m will be allocated to each portfolio company. The VC raised $500m in its first investment fund in late 2005 - to date, around 90% of the proceeds have been committed. Clarus Ventures has offices on the US east and west coast.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT046400

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel